A companion diagnostic assay is an in vitro diagnostic (IVD) device that is used to identify whether a patient with certain disease could be benefitted by a particular drug through biomarker assessment.


Visionary leaders are the leading market players in terms of new developments such as product launches, innovative technologies, and the adoption of growth strategies. These players have a broad product offering that caters to most of the regions globally. Visionary leaders primarily focus on acquiring the leading market position through their strong financial capabilities and their well-established brand equity.


Dynamic Differentiators are established players with very strong business strategies. However, they have a weaker product portfolio compared to the visionary leaders. They generally focus only on a specific type of technology related to the product.


Innovators in the competitive leadership mapping are vendors that have demonstrated substantial product innovations as compared to their competitors. The companies have focused on product portfolios. However, they do not have very strong growth strategies for their overall business, when compared with the visionary leaders.


Emerging companies have niche product and service offerings. Their business strategies are not as strong as that of the established vendors. The emerging vendors include the new entrants in the market, emerging in terms of product portfolio and geographic reach, and require time to gain significant traction in the market.

Companion Diagnostics

Comparing 25 vendors in Companion Diagnostics across 64 criteria.
All vendors(25)

Roche Holding AG, a leading leader in the health-care field, offers innovative solutions for genomics research. Their cutting-edge platforms include pathogen identification, gene expression analysis, genetic variation analysis, and next-generation sequencing, to name a few. They also provide a wide range of genomic services such as database development, data analysis, and bioinformatics. Roche's unparalleled access to the latest technologies and resources make them the go-to provider of genomics solutions and services.
Read less Read more
QIAGEN NV's USP for Companion Diagnostics provides an industry-leading portfolio for development and placement of in-vitro diagnostics. This includes support for unique sample-to-answer environments and end-to-end solutions for bioinformatics, technology and services to ensure quality results. QIAGEN NV's comprehensive platform also offers comprehensive customization of workflows and diagnostics, combining current industry standards with advanced technology solutions.
Read less Read more
Illumina Inc are leaders in the field of Companion Diagnostics, allowing customers direct access to their array of advanced solutions to facilitate the accurate, safe and timely deployment of companion diagnostics tests. Their in-depth knowledge and understanding of the clinical trial and diagnostics industry, paired with the expertise of their scientists and engineers, provides customers with innovative tools and solutions to meet their personalized needs every step of the way.
Read less Read more
Myriad Genetics Inc. is a leading provider of companion diagnostics, offering reliable and clinically valid testing for genetic tests that help clinicians better diagnose and treat their patients. Our tests identify variants in genes and genomic regions associated with hereditary conditions, drug response and disease, enabling personalized medicine. We are committed to providing actionable insights, fast turnaround times and adherence to the highest quality standards to support patient care.
Read less Read more
BIOMERIEUX SA specializes in Companion Diagnostics, an important cornerstone of personalized medicine. They offer a broad array of proprietary pre-validated biomarker assays and integrated solutions, enabling hospital laboratories and pharmaceutical companies to quickly optimize and validate companion diagnostics tests and make more confident decisions. With their cutting edge technologies, expertise, and automated options, BIOMERIEUX SA in Companion Diagnostics  is helping to advance the interests of clinicians and patients.
Read less Read more